Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

24

Revenue 2017

Eylea

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Eylea was produced by Bayer.

New eye indication for Allergan’s Ozurdex

New eye indication for Allergan’s Ozurdex Bayer's fast-growing eye drug Eylea (aflibercept) has also been recommended by the Committee for Medicinal Products for Human Use (CHMP), although final approval is still pending. ... It is a similar situation in the US where both Eylea and Lucentis are

Allergan will start phase III DARPin trials next year

Allergan will start phase III DARPin trials next year Chief executive David Pyott pointed out that Bayer's Eylea (aflibercept) has made dramatic gains in market share since launch thanks to a more favourable dosing regimen against Lucentis, which requires

Novartis and NHS launch mobile eye unit in UK

Novartis and NHS launch mobile eye unit in UK The drug was the dominant force in wet AMD treatment for some time, although is now facing a challenge from Bayer's Eylea (aflibercept), which was recommended last year. ... Little separates the two drugs in terms of effectiveness, safety and cost,

Bayer files eye drug Eylea for new use in EU

Bayer files eye drug Eylea for new use in EU Furthermore, Eylea was associated with a mean 17-letter improvement in BCVA over baseline, compared to 6.9 letters for laser treatment. ... Eylea has already been submitted for regulatory approval to treat macular oedema following BRVO in the US, where

Novartis licenses Ophthotech eye drug in $1bn deal

Novartis licenses Ophthotech eye drug in $1bn deal Competition in the AMD sector is on the increase, however, with Lucentis jostling for market share with Regeneron and Bayer's Eylea (aflibercept) as well as off-label use of

[ Previous 5 results ] 7 8 9 10 11 12 13 14 15 16 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...